Muy‐Kheng M. Tea - Concepedia

Author

Muy‐Kheng M. Tea

Also Known As

Csilla I Szabo, M Tea, M. M. Tea, Muy-Kheng M Tea, Muy-Kheng M. Tea, Muy-Kheng Maria Tea, Muy-Kheng Tea, Muy‐Kheng M. Tea, Saundra Buys, Tea, Muy-Kheng

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Comprehensive Cancer Center Vienna Memorial Sloan Kettering Cancer Center Medizinische Hochschule Hannover Dana-Farber Cancer Institute

About

Muy‐Kheng M. Tea is an author at Medical University of Vienna specializing in medicine, breast cancer, and plastic surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	155
2	Pathology	2	2	34
3	Public Health	1	1	19
4	Immunology	1	1	49
5	Molecular Genetics	1	1	15

Muy‐Kheng M. Tea

Publications

Citations

H-Index

Page 1

	Year	Citations
Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA) Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis, Cancer Epidemiology Biomarkers & Prevention	2012	649
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck, Nandita Mitra, Fei Wan, JAMA	2015	484
Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density Christopher C. Riedl, Nikolaus Luft, Clemens Bernhart, Journal of Clinical Oncology	2015	300
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 Anna Marie Mulligan, Fergus J. Couch, Daniel Barrowdale, Breast Cancer Research	2011	118
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients Eva Obermayr, Fátima Sánchez‐Cabo, Muy‐Kheng M. Tea, BMC Cancer	2010	116
Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect” Christine Staudigl, Georg Pfeiler, Katharina Hrauda, BMC Cancer	2016	62
Modification of<i>BRCA1</i>-Associated Breast and Ovarian Cancer Risk by<i>BRCA1</i>-Interacting Genes Timothy R. Rebbeck, Nandita Mitra, Susan M. Domchek, Cancer Research	2011	56
Common Variants at the 19p13.1 and <i>ZNF365</i> Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Fergus J. Couch, Mia M. Gaudet, Antonis C. Antoniou, Cancer Epidemiology Biomarkers & Prevention	2012	55
Surgical breast lesions in adolescent females Muy‐Kheng M. Tea, Ella Asseryanis, Regina Kroiss, Pediatric Surgery International Breast OncologySurgical PathologySurgical Breast LesionsBreast CancerSurgery	2008	51
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34) Christian F. Singer, Georg Pfeiler, Michael Hubalek, European Journal of Cancer VaccinationVaccine SafetyBreast OncologyOncologyEarly Breast Cancer	2020	49

Page 1